BACKGROUND: Tick-borne encephalitis virus (TBEV) is a significant threat to human health. The virus causes potentially fatal disease of the central nervous system (CNS), for which no treatments are available. TBEV infected individuals display a wide spectrum of neuronal disease, the determinants of which are undefined. Changes to host metabolism and virus-induced immunity have been postulated to contribute to the neuronal damage observed in infected individuals. In this study, we evaluated the cytokine, chemokine, and metabolic alterations in the cerebrospinal fluid (CSF) of symptomatic patients infected with TBEV presenting with meningitis or encephalitis. Our aim was to investigate the host immune and metabolic responses associated with specific TBEV infectious outcomes. METHODS: CSF samples of patients with meningitis (n = 27) or encephalitis (n = 25) were obtained upon consent from individuals hospitalised with confirmed TBEV infection in Brno. CSF from uninfected control patients was also collected for comparison (n = 12). A multiplex bead-based system was used to measure the levels of pro-inflammatory cytokines and chemokines. Untargeted metabolomics followed by bioinformatics and integrative omics were used to profile the levels of metabolites in the CSF. Human motor neurons (hMNs) were differentiated from induced pluripotent stem cells (iPSCs) and infected with the highly pathogenic TBEV-Hypr strain to profile the role(s) of identified metabolites during the virus lifecycle. Virus infection was quantified via plaque assay. RESULTS: Significant differences in proinflammatory cytokines (IFN-α2, TSLP, IL-1α, IL-1β, GM-CSF, IL-12p40, IL-15, and IL-18) and chemokines (IL-8, CCL20, and CXCL11) were detected between neurological-TBEV and control patients. A total of 32 CSF metabolites differed in TBE patients with meningitis and encephalitis. CSF S-Adenosylmethionine (SAM), Fructose 1,6-bisphosphate (FBP1) and Phosphoenolpyruvic acid (PEP) levels were 2.4-fold (range ≥ 2.3-≥3.2) higher in encephalitis patients compared to the meningitis group. CSF urocanic acid levels were significantly lower in patients with encephalitis compared to those with meningitis (p = 0.012209). Follow-up analyses showed fluctuations in the levels of O-phosphoethanolamine, succinic acid, and L-proline in the encephalitis group, and pyruvic acid in the meningitis group. TBEV-infection of hMNs increased the production of SAM, FBP1 and PEP in a time-dependent manner. Depletion of the metabolites with characterised pharmacological inhibitors led to a concentration-dependent attenuation of virus growth, validating the identified changes as key mediators of TBEV infection. CONCLUSIONS: Our findings reveal that the neurological disease outcome of TBEV infection is associated with specific and dynamic metabolic signatures in the cerebrospinal fluid. We describe a new in vitro model for in-depth studies of TBEV-induced neuropathogenesis, in which the depletion of identified metabolites limits virus infection. Collectively, this reveals new biomarkers that can differentiate and predict TBEV-associated neurological disease. Additionally, we have identified novel therapeutic targets with the potential to significantly improve patient outcomes and deepen our understanding of TBEV pathogenesis.

• Klíčová slova
• Cerebrospinal fluid, Chemokines, Human motor neurons, Metabolomics, Neuroinflammation, Pro-inflammatory cytokines, Tick-borne encephalitis virus,
• MeSH
• cytokiny mozkomíšní mok   MeSH
• dospělí MeSH
• klíšťová encefalitida * mozkomíšní mok   metabolismus   MeSH
• kultivované buňky MeSH
• lidé středního věku MeSH
• lidé MeSH
• metabolom * fyziologie   MeSH
• metabolomika MeSH
• mladý dospělý MeSH
• neurony * metabolismus   virologie   MeSH
• senioři MeSH
• viry klíšťové encefalitidy * MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• cytokiny MeSH

BACKGROUND: Tick-borne encephalitis (TBE) is the most common tick-borne viral infection in Eurasia. Outcomes range from asymptomatic infection to fatal encephalitis, with host genetics likely playing a role. BALB/c mice have intermediate susceptibility to TBE virus (TBEV) and STS mice are highly resistant, whereas the recombinant congenic strain CcS-11, which carries 12.5% of the STS genome on the BALB/c background, is more susceptible than BALB/c mice. In the present study, we employed these genetically distinct mouse models to investigate the host response to TBEV infection in both peripheral macrophages, one of the initial target cell populations, and the brain, the terminal target organ of the virus. METHODS: TBEV growth and the production of key cytokines and chemokines were measured and compared in macrophages derived from BALB/c, CcS-11, and STS mice. In addition, brains from these TBEV-infected mouse strains underwent in-depth transcriptomic analysis. RESULTS: Virus production in BALB/c and CcS-11 macrophages exhibited similar kinetics 24 and 48 h post-infection (hpi), but CcS-11 macrophages yielded significantly higher titers 72 hpi. Macrophages from both sensitive strains demonstrated elevated chemokine and proinflammatory cytokine production upon infection, whereas the resistant strain, STS, showed no cytokine/chemokine activation. Transcriptomic analysis of brain tissue demonstrated that the genetic background of the mouse strains dictated their transcriptional response to infection. The resistant strain exhibited a more robust cell-mediated immune response, whereas both sensitive strains showed a less effective cell-mediated response but increased cytokine signaling and signs of demyelination, with loss of oligodendrocytes. CONCLUSIONS: Our findings suggest that variations in susceptibility linked to host genetic background correspond with distinct host responses, both in the periphery upon virus entry into the organism and in the brain, the target organ of the virus. These results provide insights into the influence of host genetics on the clinical trajectory of TBE.

• Klíčová slova
• Genetics, Macrophages, Mouse model, Neuroinflammation, Tick-borne encephalitis, Tick-borne encephalitis virus, Transcriptomics,
• MeSH
• cytokiny metabolismus   MeSH
• genetická predispozice k nemoci * MeSH
• genotyp MeSH
• klíšťová encefalitida * genetika   imunologie   patologie   virologie   MeSH
• makrofágy * virologie   imunologie   metabolismus   MeSH
• mozek * virologie   imunologie   patologie   metabolismus   MeSH
• myši inbrední BALB C MeSH
• myši MeSH
• viry klíšťové encefalitidy * MeSH
• zvířata MeSH
• Check Tag
• myši MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• cytokiny MeSH

In RNA interference (RNAi), long double-stranded RNA is cleaved by the Dicer endonuclease into small interfering RNAs (siRNAs), which guide degradation of complementary RNAs. While RNAi mediates antiviral innate immunity in plants and many invertebrates, vertebrates have adopted a sequence-independent response and their Dicer produces siRNAs inefficiently because it is adapted to process small hairpin microRNA precursors in the gene-regulating microRNA pathway. Mammalian endogenous RNAi is thus a rudimentary pathway of unclear significance. To investigate its antiviral potential, we modified the mouse Dicer locus to express a truncated variant (DicerΔHEL1) known to stimulate RNAi and we analyzed how DicerΔHEL1/wt mice respond to four RNA viruses: coxsackievirus B3 and encephalomyocarditis virus from Picornaviridae; tick-borne encephalitis virus from Flaviviridae; and lymphocytic choriomeningitis virus (LCMV) from Arenaviridae. Increased Dicer activity in DicerΔHEL1/wt mice did not elicit any antiviral effect, supporting an insignificant antiviral function of endogenous mammalian RNAi in vivo. However, we also observed that sufficiently high expression of DicerΔHEL1 suppressed LCMV in embryonic stem cells and in a transgenic mouse model. Altogether, mice with increased Dicer activity offer a new benchmark for identifying and studying viruses susceptible to mammalian RNAi in vivo.

In RNA interference (RNAi), the enzyme Dicer cuts long double-stranded RNA into small interfering RNAs that degrade matching RNAs. RNAi is a key antiviral defense in plants and invertebrates but vertebrates evolved a principally different antiviral defense. The authors genetically modified Dicer in mice to activate RNAi in mammals. These modified mice were tested against four RNA viruses but showed no significant antiviral response. However, further increased expression of modified Dicer did suppress one virus (lymphocytic choriomeningitis virus) in embryonic stem cells and in a transgenic mouse model, suggesting that some viruses might be sensitive to increased RNAi activity in mammals.

• MeSH
• DEAD-box RNA-helikasy genetika   metabolismus   MeSH
• malá interferující RNA genetika   MeSH
• myši inbrední C57BL MeSH
• myši MeSH
• přirozená imunita * genetika   MeSH
• ribonukleasa III * genetika   metabolismus   MeSH
• RNA interference * MeSH
• virus encefalomyokarditidy genetika   imunologie   MeSH
• virus lymfocytární choriomeningitidy imunologie   genetika   MeSH
• viry klíšťové encefalitidy genetika   imunologie   MeSH
• zvířata MeSH
• Check Tag
• myši MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• DEAD-box RNA-helikasy MeSH
• Dicer1 protein, mouse MeSH Prohlížeč
• malá interferující RNA MeSH
• ribonukleasa III * MeSH

Tick-borne encephalitis (TBE) virus (TBEV) is transmitted to humans via tick bites. Infection is benign in >90% of the cases but can cause mild (<5%), moderate (<4%), or severe (<1%) encephalitis. We show here that ∼10% of patients hospitalized for severe TBE in cohorts from Austria, Czech Republic, and France carry auto-Abs neutralizing IFN-α2, -β, and/or -ω at the onset of disease, contrasting with only ∼1% of patients with moderate and mild TBE. These auto-Abs were found in two of eight patients who died and none of 13 with silent infection. The odds ratios (OR) for severe TBE in individuals with these auto-Abs relative to those without them in the general population were 4.9 (95% CI: 1.5-15.9, P < 0.0001) for the neutralization of only 100 pg/ml IFN-α2 and/or -ω, and 20.8 (95% CI: 4.5-97.4, P < 0.0001) for the neutralization of 10 ng/ml IFN-α2 and -ω. Auto-Abs neutralizing type I IFNs accounted for ∼10% of severe TBE cases in these three European cohorts.

• MeSH
• autoprotilátky * imunologie   MeSH
• dospělí MeSH
• interferon typ I * imunologie   MeSH
• klíšťová encefalitida * imunologie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• neutralizující protilátky * imunologie   MeSH
• senioři MeSH
• viry klíšťové encefalitidy imunologie   MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Česká republika MeSH
• Rakousko epidemiologie   MeSH
• Názvy látek
• autoprotilátky * MeSH
• interferon typ I * MeSH
• neutralizující protilátky * MeSH

Tick-borne encephalitis virus (TBEV) targets the central nervous system (CNS), leading to potentially severe neurological complications. The neurovascular unit plays a fundamental role in the CNS and in the neuroinvasion of TBEV. However, the role of human brain pericytes, a key component of the neurovascular unit, during TBEV infection has not yet been elucidated. In this study, TBEV infection of the primary human brain perivascular pericytes was investigated with highly virulent Hypr strain and mildly virulent Neudoerfl strain. We used Luminex assay to measure cytokines/chemokines and growth factors. Both viral strains showed comparable replication kinetics, peaking at 3 days post infection (dpi). Intracellular viral RNA copies peaked at 6 dpi for Hypr and 3 dpi for Neudoerfl cultures. According to immunofluorescence staining, only small proportion of pericytes were infected (3% for Hypr and 2% for Neudoerfl), and no cytopathic effect was observed in the infected cells. In cell culture supernatants, IL-6 production was detected at 3 dpi, together with slight increases in IL-15 and IL-4, but IP-10, RANTES and MCP-1 were the main chemokines released after TBEV infection. These chemokines play key roles in both immune defense and immunopathology during TBE. This study suggests that pericytes are an important source of these signaling molecules during TBEV infection in the brain.

• Klíčová slova
• CCL5, CXCL10, chemokine, flavivirus, human pericytes, infection, inflammation, tick-borne encephalitis virus,
• MeSH
• chemokin CCL5 * metabolismus   MeSH
• chemokin CXCL10 * metabolismus   MeSH
• cytokiny metabolismus   MeSH
• klíšťová encefalitida * virologie   metabolismus   MeSH
• kultivované buňky MeSH
• lidé MeSH
• mozek * virologie   metabolismus   patologie   MeSH
• pericyty * virologie   metabolismus   MeSH
• replikace viru MeSH
• viry klíšťové encefalitidy * fyziologie   patogenita   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• CCL5 protein, human MeSH Prohlížeč
• chemokin CCL5 * MeSH
• chemokin CXCL10 * MeSH
• CXCL10 protein, human MeSH Prohlížeč
• cytokiny MeSH

Tick-borne encephalitis virus (TBEV), the most medically relevant tick-transmitted flavivirus in Eurasia, targets the host central nervous system and frequently causes severe encephalitis. The severity of TBEV-induced neuropathogenesis is highly cell-type specific and the exact mechanism responsible for such differences has not been fully described yet. Thus, we performed a comprehensive analysis of alterations in host poly-(A)/miRNA/lncRNA expression upon TBEV infection in vitro in human primary neurons (high cytopathic effect) and astrocytes (low cytopathic effect). Infection with severe but not mild TBEV strain resulted in a high neuronal death rate. In comparison, infection with either of TBEV strains in human astrocytes did not. Differential expression and splicing analyses with an in silico prediction of miRNA/mRNA/lncRNA/vd-sRNA networks found significant changes in inflammatory and immune response pathways, nervous system development and regulation of mitosis in TBEV Hypr-infected neurons. Candidate mechanisms responsible for the aforementioned phenomena include specific regulation of host mRNA levels via differentially expressed miRNAs/lncRNAs or vd-sRNAs mimicking endogenous miRNAs and virus-driven modulation of host pre-mRNA splicing. We suggest that these factors are responsible for the observed differences in the virulence manifestation of both TBEV strains in different cell lines. This work brings the first complex overview of alterations in the transcriptome of human astrocytes and neurons during the infection by two TBEV strains of different virulence. The resulting data could serve as a starting point for further studies dealing with the mechanism of TBEV-host interactions and the related processes of TBEV pathogenesis.

• Klíčová slova
• A3SS, alternative 3′ splice site, A5SS, alternative 5′ splice site, ACACA, Acetyl-CoA Carboxylase Alpha, AKR1C2, Aldo-Keto Reductase Family 1 Member C2, ANKS1A, Ankyrin Repeat And Sterile Alpha Motif Domain Containing 1A, ANOS1, Anosmin 1, AOX1, Aldehyde Oxidase 1, APOBEC3G, Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G, APOL1/6, Apolipoprotein L1/6, ARID2, AT-Rich Interaction Domain 2, AUTS2, Activator Of Transcription And Developmental Regulator AUTS2, Alternative splicing, Astrocytes, BCL11B, BAF Chromatin Remodeling Complex Subunit BCL11B, BCL9L, BCL9 Transcription Coactivator-like, BDKRB2, Bradykinin Receptor B2, BDNF, Brain Derived Neurotrophic Factor, BEND3, BEN Domain Containing 3, BSA, bovine serum albumin, BST2, Bone Marrow Stromal Cell Antigen 2, CALB1, Calbindin 1, CAMK2A, Calcium/Calmodulin Dependent Protein Kinase II Alpha, CD, complement determinant, CDKN1C, Cyclin Dependent Kinase Inhibitor 1C, CFAP61, Cilia And Flagella Associated Protein 61, CHRNA3, Cholinergic Receptor Nicotinic Alpha 3 Subunit, CHRNB4, Cholinergic Receptor Nicotinic Beta 4 Subunit, CLIC5, Chloride Intracellular Channel 5, CMPK2, Cytidine/Uridine Monophosphate Kinase 2, CNS, central nervous system, CNTN2, Contactin 2, CREG2, Cellular Repressor Of E1A Stimulated Genes 2, CXADR, Coxsackievirus B-Adenovirus Receptor, CYYR1, Cysteine And Tyrosine Rich 1, DACH1, Dachshund Family Transcription Factor 1, DAPI, diamidino-2-phenylindole, DCC, Netrin 1 Receptor, DCX, Doublecortin, DDX60, DExD/H-Box Helicase 60, DDX60L, DExD/H-Box 60 Like, DE, differentially expressed, DENV, Dengue virus, DIRAS2, DIRAS Family GTPase 2, DLX1/5/6, Distal-Less Homeobox 1/5/6, DNMT3B, DNA Methyltransferase 3 Beta, DPYSL2, Dihydropyrimidinase Like 2, EBF1, EBF Transcription Factor 1, EGF, Epidermal Growth Factor, ELAVL2/4, ELAV Like RNA Binding Protein 2/4, EPHB1, EPH Receptor B1, EPSTI1, Epithelial Stromal Interaction 1, ERBB4, Erb-B2 Receptor Tyrosine Kinase 4, ES, exon skipping, ESRRG, Estrogen Related Receptor Gamma, FGFb, Fibroblast Growth Factor 2, FPKM, Fragments Per Kilobase of transcript per Million mapped reads, FUT9, Fucosyltransferase 9, G2E3, G2/M−Phase Specific E3 Ubiquitin Protein Ligase, GABRG2, Gamma-Aminobutyric Acid Type A Receptor Subunit Gamma 2, GAPDH, Glyceraldehyde-3-Phosphate Dehydrogenase, GAS2L3, Growth Arrest Specific 2 Like 3, GAS7, Growth Arrest Specific 7, GATAD2B, GATA Zinc Finger Domain Containing 2B, GFAP, Glial Fibrillary Acidic Protein, GIPC2, GIPC PDZ Domain Containing Family Member 2, GLRA2, Glycine Receptor Alpha 2, GNG2, G Protein Subunit Gamma 2, GO, gene ontology, GOLGA4, Golgin A4, GRIN2A, Glutamate Ionotropic Receptor NMDA Type Subunit 2A, GSEA, gene set enrichment analysis, HERC5/6, HECT And RLD Domain Containing E3 Ubiquitin Protein Ligase 5/6, HEYL, Hes Related Family BHLH Transcription Factor With YRPW Motif Like, HPRT1, Hypoxanthine Phosphoribosyltransferase 1, HS, hot-spot, HSPA6, Heat Shock Protein Family A (Hsp70) Member 6, HUDD (ELAV4), Hu-Antigen D/ELAV Like Neuron-Specific RNA Binding Protein 4, IFI6, Interferon Alpha Inducible Protein 6, IFIH1 (MDA5), Interferon Induced With Helicase C Domain 1/Melanoma Differentiation-Associated Protein 5, IFIT1-3, Interferon Induced Protein With Tetratricopeptide Repeats 1–3, IFITM1/2, Interferon Induced Transmembrane Protein 1/2, IFN, interferon, IGB, Integrated Genome Browser, IL6, Interleukin 6, IR, intron retention, ISG20, Interferon Stimulated Exonuclease Gene 20, ISGF3, Interferon-Stimulated Gene Factor 3 Gamma, ISGs, interferon-stimulated genes, JEV, Japanese encephalitis virus, KCND2, Potassium Voltage-Gated Channel Subfamily D Member 2, KCNK10, Potassium Two Pore Domain Channel Subfamily K Member 10, KCNS2, Potassium Voltage-Gated Channel Modifier Subfamily S Member 2, KIT, KIT Proto-Oncogene, Receptor Tyrosine Kinase, KLHDC8A, Kelch Domain Containing 8A, KLHL13, Kelch Like Family Member 13, KRR1, KRR1 Small Subunit Processome Component Homolog, LCOR, Ligand Dependent Nuclear Receptor Corepressor, LEKR1, Leucine, Glutamate And Lysine Rich 1, LGI1, Leucine Rich Glioma Inactivated 1, LRRTM3, Leucine Rich Repeat Transmembrane Neuronal 3, LSV, local splicing variation, LUZP2, Leucine Zipper Protein 2, MAN1A1, Mannosidase Alpha Class 1A Member 1, MAP2, Microtubule Associated Protein 2, MBNL2, Muscleblind Like Splicing Regulator 2, MCTP1, Multiple C2 And Transmembrane Domain Containing 1, MMP13, Matrix Metallopeptidase 13, MN1, MN1 Proto-Oncogene, Transcriptional Regulator, MOI, multiplicity of infection, MTUS2, Microtubule Associated Scaffold Protein 2, MX2, MX Dynamin Like GTPase 2, MYCN, MYCN Proto-Oncogene, BHLH Transcription Factor, NAV1, Neuron Navigator 1, NCAM1, Neural Cell Adhesion Molecule 1, NDRG4, N-Myc Downstream-Regulated Gene 4 Protein, NEK7, NIMA Related Kinase 7, NFASC, Neurofascin, NKAIN1, Sodium/Potassium Transporting ATPase Interacting 1, NMI, N-Myc And STAT Interactor 2, NRAP, Nebulin Related Anchoring Protein, NRARP, NOTCH Regulated Ankyrin Repeat Protein, NREP, Neuronal Regeneration Related Protein, NRN1, Neuritin 1, NS3, flaviviral non-structural protein 3, NXPH2, Neurexophilin 2, NYNRIN, NYN Domain And Retroviral Integrase Containing, Neurons, Neuropathogenesis, OAS, 2′-5′-Oligoadenylate Synthetase, OASL, 2′-5′-Oligoadenylate Synthetase Like, ONECUT2, ONECUT-2 Homeodomain Transcription Factor, OPCML, Opioid Binding Protein/Cell Adhesion Molecule Like, OTX2, Orthodenticle Homeobox 2, PBS, phosphate buffer saline, PBX1, Pre-B-Cell Leukemia Transcription Factor 1, PCDH18/20, Protocadherin 18/20, PFKFB3, 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3, PIK3C2B, Phosphatidylinositol-4-Phosphate 3-Kinase Catalytic Subunit Type 2 Beta, PIP4P2, Phosphatidylinositol-4,5-Bisphosphate 4-Phosphatase 2, PLCH1, Phospholipase C Eta 1, POU3F4, Brain-Specific Homeobox/POU Domain Protein 4, PPM1L, Protein Phosphatase, Mg2+/Mn2+ Dependent 1L, PPP1R17, Protein Phosphatase 1 Regulatory Subunit 17, PRDM12, PR Domain Zinc Finger Protein 12, PSI, percent selective index, PSRC1, Proline And Serine Rich Coiled-Coil 1, PTPN5, Protein Tyrosine Phosphatase Non-Receptor Type 5, PTPRH, Protein Tyrosine Phosphatase Receptor Type H, RAPGEF5, Rap Guanine Nucleotide Exchange Factor 5, RBFOX1, RNA Binding Fox-1 Homolog 1, RIG-I (DDX58), Retinoic Acid-Inducible Gene 1 Protein, RNF212, Ring Finger Protein 212, RNVU1, RNA, Variant U1 Small Nuclear, RSAD2, Radical S-Adenosyl Methionine Domain Containing 2, RTL8B, Retrotransposon Gag Like 8B, Response to infection, SAMD9, Sterile Alpha Motif Domain Containing 9, SEMA3E, Semaphorin 3E, SH3TC2, SH3 Domain And Tetratricopeptide Repeats 2, SHF, Src Homology 2 Domain Containing F, SHISAL1, Shisa Like 1, SIAH3, Siah E3 Ubiquitin Protein Ligase Family Member 3, SIRPA, Signal Regulatory Protein Alpha, SLITRK5, SLIT And NTRK Like Family Member 5, SNP, single-nucleotide polymorphism, SOGA1, Suppressor Of Glucose, Autophagy Associated 1, SPSB4, SplA/Ryanodine Receptor Domain And SOCS Box Containing 4, ST6GAL1, ST6 Beta-Galactoside Alpha-2,6-Sialyltransferase 1, TBC1D30, TBC1 Domain Family Member 30, TBEV, Tick-borne encephalitis virus, TFAP2A, Transcription Factor AP-2 Alpha, TFAP2B, Transcription Factor AP-2 Beta, THSD7A, Thrombospondin Type 1 Domain Containing 7A, THUMPD2, THUMP Domain-Containing Protein 2/SAM-Dependent Methyltransferase, TIPARP, TCDD Inducible Poly(ADP-Ribose) Polymerase, TM4SF18, Transmembrane 4 L Six Family Member 18, TMC8, Transmembrane Channel Like 6, TMEM229B, Transmembrane Protein 229B, TMTC1, Transmembrane O-Mannosyltransferase Targeting Cadherins 1, TNFSF10, TNF Superfamily Member 10, TRHDE, Thyrotropin Releasing Hormone Degrading Enzyme, TRIM38, Tripartite Motif Containing 38, TSHZ1, Teashirt Zinc Finger Homeobox 1, Tick-borne encephalitis virus, Transcriptomics, USP18, Ubiquitin Specific Peptidase 18/ISG15-Specific-Processing Protease, UTR, untranslated region, UTS2R, Urotensin 2 Receptor, WNV, West Nile virus, XAF1, XIAP Associated Factor 1, XRN1, 5′-3′ Exoribonuclease 1, ZIKV, Zika virus, ZMAT3, Zinc Finger Matrin-Type 3, ZMYM5, Zinc Finger MYM-Type Containing 5, ZNF124, Zinc Finger Protein 124, ZNF730, Zinc Finger Protein 730, gRNA, genomic TBEV RNA, hNSC, human neural stem cells, lncRNA, long non-coding RNA, mRNA, messenger RNA, miRNA, miRNA, micro RNA, ncRNA, non-coding RNA, pc-mRNA, protein-coding mRNA, qRT-PCR, quantitative reverse transcription real-time PCR, snRNP, small nuclear ribonucleoproteins, vd-sRNA, virus-derived small RNA,
• Publikační typ
• časopisecké články MeSH

The aim of this review is to follow the history of studies on endemiv arboviruses and the diseases they cause which were detected in the Czech lands (Bohemia, Moravia and Silesia (i.e., the Czech Republic)). The viruses involve tick-borne encephalitis, West Nile and Usutu flaviviruses; the Sindbis alphavirus; Ťahyňa, Batai, Lednice and Sedlec bunyaviruses; the Uukuniemi phlebovirus; and the Tribeč orbivirus. Arboviruses temporarily imported from abroad to the Czech Republic have been omitted. This brief historical review includes a bibliography of all relevant papers.

• Klíčová slova
• arthropods, birds, mammals, mosquitoes, ticks,
• MeSH
• arbovirové infekce dějiny   MeSH
• arboviry fyziologie   MeSH
• dějiny 20. století MeSH
• dějiny 21. století MeSH
• lidé MeSH
• zvířata MeSH
• Check Tag
• dějiny 20. století MeSH
• dějiny 21. století MeSH
• lidé MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• historické články MeSH
• přehledy MeSH
• Geografické názvy
• Česká republika epidemiologie   MeSH

Tick-borne encephalitis virus (TBEV) is an emerging human pathogen that causes potentially fatal disease with no specific treatment. Mouse monoclonal antibodies are protective against TBEV, but little is known about the human antibody response to infection. Here, we report on the human neutralizing antibody response to TBEV in a cohort of infected and vaccinated individuals. Expanded clones of memory B cells expressed closely related anti-envelope domain III (EDIII) antibodies in both groups of volunteers. However, the most potent neutralizing antibodies, with IC50s below 1 ng/ml, were found only in individuals who recovered from natural infection. These antibodies also neutralized other tick-borne flaviviruses, including Langat, louping ill, Omsk hemorrhagic fever, Kyasanur forest disease, and Powassan viruses. Structural analysis revealed a conserved epitope near the lateral ridge of EDIII adjoining the EDI-EDIII hinge region. Prophylactic or early therapeutic antibody administration was effective at low doses in mice that were lethally infected with TBEV.

• MeSH
• analýza přežití MeSH
• epitopy imunologie   MeSH
• imunoglobulin G aplikace a dávkování   imunologie   MeSH
• klíšťová encefalitida imunologie   prevence a kontrola   virologie   MeSH
• kohortové studie MeSH
• kultivované buňky MeSH
• lidé MeSH
• monoklonální protilátky aplikace a dávkování   genetika   imunologie   MeSH
• myši inbrední BALB C MeSH
• myši MeSH
• neutralizující protilátky aplikace a dávkování   genetika   imunologie   MeSH
• proteiny virového obalu genetika   imunologie   MeSH
• protilátky virové aplikace a dávkování   genetika   imunologie   MeSH
• sekvence aminokyselin MeSH
• sekvenční homologie aminokyselin MeSH
• viry klíšťové encefalitidy účinky léků   imunologie   fyziologie   MeSH
• zkřížené reakce imunologie   MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• myši MeSH
• ženské pohlaví MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Research Support, N.I.H., Extramural MeSH
• Research Support, U.S. Gov't, Non-P.H.S. MeSH
• Názvy látek
• epitopy MeSH
• imunoglobulin G MeSH
• monoklonální protilátky MeSH
• neutralizující protilátky MeSH
• proteiny virového obalu MeSH
• protilátky virové MeSH

Tick-borne encephalitis virus (TBEV) is a leading cause of vector-borne viral encephalitis with expanding endemic regions across Europe. In this study we tested in mice the efficacy of preinfection with a closely related low-virulent flavivirus, Langat virus (LGTV strain TP21), or a naturally avirulent TBEV strain (TBEV-280) in providing protection against lethal infection with the highly virulent TBEV strain (referred to as TBEV-Hypr). We show that prior infection with TP21 or TBEV-280 is efficient in protecting mice from lethal TBEV-Hypr challenge. Histopathological analysis of brains from nonimmunized mice revealed neuronal TBEV infection and necrosis. Neuroinflammation, gliosis, and neuronal necrosis was however also observed in some of the TP21 and TBEV-280 preinfected mice although at reduced frequency as compared to the nonimmunized TBEV-Hypr infected mice. qPCR detected the presence of viral RNA in the CNS of both TP21 and TBEV-280 immunized mice after TBEV-Hypr challenge, but significantly reduced compared to mock-immunized mice. Our results indicate that although TBEV-Hypr infection is effectively controlled in the periphery upon immunization with low-virulent LGTV or naturally avirulent TBEV 280, it may still enter the CNS of these animals. These findings contribute to our understanding of causes for vaccine failure in individuals vaccinated with TBE vaccines.

• Klíčová slova
• CNS, Langat virus, neuronal damage, tick-borne encephalitis virus, virus induced immunity,
• Publikační typ
• časopisecké články MeSH